Black Rock Inc. Soma Logic, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.76 - $2.83 $1.06 Million - $1.7 Million	600,516 Added 5.49%	11,548,774 $29.2 Million
Q3 2023 Nov 13, 2023	SELL	$1.99 - $2.45 $30,164 - $37,137	-15,158 Reduced 0.14%	10,948,258 $26.2 Million
Q2 2023 Aug 11, 2023	BUY	$2.1 - $3.36 $598,033 - $956,854	284,778 Added 2.67%	10,963,416 $25.3 Million
Q1 2023 May 12, 2023	BUY	$2.13 - $3.6 $874,060 - $1.48 Million	410,357 Added 4.0%	10,678,638 $27.2 Million
Q4 2022 Feb 13, 2023	BUY	$2.05 - $3.47 $1.08 Million - $1.84 Million	529,068 Added 5.43%	10,268,281 $25.8 Million
Q3 2022 Nov 14, 2022	SELL	$0.63 - $5.47 $19,538 - $169,646	-31,014 Reduced 0.32%	9,739,213 $28.2 Million
Q2 2022 Aug 12, 2022	BUY	$4.27 - $8.26 $32.9 Million - $63.7 Million	7,712,881 Added 374.89%	9,770,227 $44.2 Million
Q1 2022 May 12, 2022	BUY	$7.07 - $11.62 $699,859 - $1.15 Million	98,990 Added 5.05%	2,057,346 $16.5 Million
Q4 2021 Feb 10, 2022	BUY	$10.49 - $14.28 $20.5 Million - $28 Million	1,958,356 New	1,958,356 $22.8 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.